- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 395785, 9 pages
Epoetin Delta Reduces Oxidative Stress in Primary Human Renal Tubular Cells
1Laboratory of Pathophysiology, Faculties of Medicine and Biomedical, Pharmaceutical and Veterinary Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
2Department of Nephrology, The Second Hospital, Shandong University, Jinan 250033, China
Received 16 November 2009; Revised 17 February 2010; Accepted 17 February 2010
Academic Editor: Xudong Huang
Copyright © 2010 Annelies De Beuf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. W. Dryden Jr., I. Deaciuc, G. Arteel, and C. J. McClain, “Clinical implications of oxidative stress and antioxidant therapy,” Current Gastroenterology Reports, vol. 7, no. 4, pp. 308–316, 2005.
- L. Forsberg, U. de Faire, and R. Morgenstern, “Oxidative stress, human genetic variation, and disease,” Archives of Biochemistry and Biophysics, vol. 389, no. 1, pp. 84–93, 2001.
- J.-C. Lee, J. Kim, J.-K. Park, G.-H. Chung, and Y.-S. Jang, “The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis,” Experimental Cell Research, vol. 291, no. 2, pp. 386–397, 2003.
- C. A. Rice-Evans, N. J. Miller, P. G. Bolwell, P. M. Bramley, and J. B. Pridham, “The relative antioxidant activities of plant-derived polyphenolic flavonoids,” Free Radical Research, vol. 22, no. 4, pp. 375–383, 1995.
- P. Katavetin, K. Tungsanga, S. Eiam-Ong, and M. Nangaku, “Antioxidative effects of erythropoietin,” Kidney International, no. 107, pp. S10–S15, 2007.
- F. H. Bahlmann and D. Fliser, “Erythropoietin and renoprotection,” Current Opinion in Nephrology and Hypertension, vol. 18, no. 1, pp. 15–20, 2009.
- M. J. F. Helbert, S. E. H. Dauwe, I. Van der Biest, E. J. Nouwen, and M. E. De Broe, “Immunodissection of the human proximal nephron: flow sorting of S1S2SS3, S1S2 and S3 proximal tubular cells,” Kidney International, vol. 52, no. 2, pp. 414–428, 1997.
- M. J. F. Helbert, S. E. H. Dauwe, and M. E. De Broe, “Flow cytometric immunodissection of the human distal tubule and cortical collecting duct system,” Kidney International, vol. 59, no. 2, pp. 554–564, 2001.
- R. E. Gibson-D'Ambrosio, M. Samuel, C. C. Chang, J. E. Trosko, and S. M. D'Ambrosio, “Characteristics of long-term human epithelial cell cultures derived from normal human fetal kidney,” In Vitro Cellular & Developmental Biology, vol. 23, no. 4, pp. 279–287, 1987.
- A. Barbouti, P.-T. Doulias, L. Nousis, M. Tenopoulou, and D. Galaris, “DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of ,” Free Radical Biology and Medicine, vol. 33, no. 5, pp. 691–702, 2002.
- H. Gong, W. Wang, T.-H. Kwon, et al., “EPO and -MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney,” Kidney International, vol. 66, no. 2, pp. 683–695, 2004.
- D. A. Vesey, C. Cheung, B. Pat, Z. Endre, G. Gobé, and D. W. Johnson, “Erythropoietin protects against ischaemic acute renal injury,” Nephrology Dialysis Transplantation, vol. 19, no. 2, pp. 348–355, 2004.
- A. Kirkeby, J. van Beek, J. Nielsen, M. Leist, and L. Helboe, “Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor,” Journal of Neuroscience Methods, vol. 164, no. 1, pp. 50–58, 2007.
- Y. Li, G. Takemura, H. Okada, et al., “Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure,” Cardiovascular Research, vol. 71, no. 4, pp. 684–694, 2006.
- F. Pajonk, A. Weil, A. Sommer, R. Suwinski, and M. Henke, “The erythropoietin-receptor pathway modulates survival of cancer cells,” Oncogene, vol. 23, no. 55, pp. 8987–8991, 2004.
- A. De Beuf, A. Verhulst, M. Helbert, et al., “Tubular erythropoietin receptor expression mediates erythropoietin-induced renoprotection,” The Open Hematology Journal, vol. 3, pp. 1–10, 2009.
- K. A. Kirkby and C. A. Adin, “Products of heme oxygenase and their potential therapeutic applications,” American Journal of Physiology, vol. 290, no. 3, pp. F563–F571, 2006.
- M. Wagner, P. Cadetg, R. Ruf, L. Mazzucchelli, P. Ferrari, and C. A. Redaelli, “Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts,” Kidney International, vol. 63, no. 4, pp. 1564–1573, 2003.
- T. D. Blydt-Hansen, M. Katori, C. Lassman, et al., “Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. 745–754, 2003.
- P. Katavetin, R. Inagi, T. Miyata, et al., “Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress,” Biochemical and Biophysical Research Communications, vol. 359, no. 4, pp. 928–934, 2007.
- S. W. Ryter and A. M. K. Choi, “Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 3, pp. 251–260, 2009.
- S. Nielsen, J. Frøkiaer, D. Marples, T.-H. Kwon, P. Agre, and M. A. Knepper, “Aquaporins in the kidney: from molecules to medicine,” Physiological Reviews, vol. 82, no. 1, pp. 205–244, 2002.
- M. Echevarría, A. M. Muñoz-Cabello, R. Sánchez-Silva, J. J. Toledo-Aral, and J. López-Barneo, “Development of cytosolic hypoxia and hypoxia-inducible factor stabilization are facilitated by aquaporin-1 expression,” Journal of Biological Chemistry, vol. 282, no. 41, pp. 30207–30215, 2007.
- E. J. Sharples, N. Patel, P. Brown, et al., “Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2115–2124, 2004.
- C. W. Yang, C. Li, J. Y. Jung, et al., “Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney,” The FASEB Journal, vol. 17, no. 12, pp. 1754–1755, 2003.
- D. Reverter, K. Maskos, F. Tan, R. A. Skidgel, and W. Bode, “Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity,” Journal of Molecular Biology, vol. 338, no. 2, pp. 257–269, 2004.
- K. Deiteren, G. Surpateanu, K. Gilany, et al., “The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over,” Biochimica et Biophysica Acta, vol. 1774, no. 2, pp. 267–277, 2007.
- K. Deiteren, D. Hendriks, S. Scharpé, and A. M. Lambeir, “Carboxypeptidase M: multiple alliances and unknown partners,” Clinica Chimica Acta, vol. 399, no. 1-2, pp. 24–39, 2009.
- G. B. McGwire, R. P. Becker, and R. A. Skidgel, “Carboxypeptidase M, a glycosylphosphatidylinositol-anchored protein, is localized on both the apical and basolateral domains of polarized Madin-Darby canine kidney cells,” Journal of Biological Chemistry, vol. 274, no. 44, pp. 31632–31640, 1999.
- Y. Nishioka, T. Higuchi, Y. Sato, et al., “Human migrating extravillous trophoblasts express a cell surface peptidase, carboxypeptidase-M,” Molecular Human Reproduction, vol. 9, no. 12, pp. 799–806, 2003.
- A.-M. Lambeir, C. Durinx, S. Scharpé, and I. De Meester, “Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 3, pp. 209–294, 2003.
- A.-M. Lambeir, S. Scharpé, and I. De Meester, “DPP4 inhibitors for diabetes—what next?” Biochemical Pharmacology, vol. 76, no. 12, pp. 1637–1643, 2008.
- W. Zhai, M. Cardell, I. De Meester, et al., “Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia,” Journal of Heart and Lung Transplantation, vol. 26, no. 2, pp. 174–180, 2007.
- F. J. Jung, L. Yang, I. De Meester, et al., “CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats,” Journal of Heart and Lung Transplantation, vol. 25, no. 9, pp. 1109–1116, 2006.
- A. Belyaev, X. Zhang, K. Augustyns, et al., “Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors,” Journal of Medicinal Chemistry, vol. 42, no. 6, pp. 1041–1052, 1999.
- A. J. Kenny, A. G. Booth, and S. G. George, “Dipeptidyl peptidase IV, a kidney brush border serine peptidase,” Biochemical Journal, vol. 157, no. 1, pp. 169–182, 1976.
- H. Fujiwara, T. Higuchi, Y. Sato, et al., “Regulation of human extravillous trophoblast function by membrane-bound peptidases,” Biochimica et Biophysica Acta, vol. 1751, no. 1, pp. 26–32, 2005.
- E. Fordel, E. Geuens, S. Dewilde, W. De Coen, and L. Moens, “Hypoxia/ischemia and the regulation of neuroglobin and cytoglobin expression,” IUBMB Life, vol. 56, no. 11-12, pp. 681–687, 2004.
- A. Pesce, M. Bolognesi, A. Bocedi, et al., “Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family,” EMBO Reports, vol. 3, no. 12, pp. 1146–1151, 2002.
- A. Shigematsu, Y. Adachi, J. Matsubara, et al., “Analyses of expression of cytoglobin by immunohistochemical studies in human tissues,” Hemoglobin, vol. 32, no. 3, pp. 287–296, 2008.
- T. Burmester, F. Gerlach, and T. Hankeln, “Regulation and role of neuroglobin and cytoglobin under hypoxia,” Advances in Experimental Medicine and Biology, vol. 618, pp. 169–180, 2007.
- N. J. Hodges, N. Innocent, S. Dhanda, and M. Graham, “Cellular protection from oxidative DNA damage by over-expression of the novel globin cytoglobin in vitro,” Mutagenesis, vol. 23, no. 4, pp. 293–298, 2008.
- R. Xu, P. M. Harrison, M. Chen, et al., “Cytoglobin overexpression protects against damage-induced fibrosis,” Molecular Therapy, vol. 13, no. 6, pp. 1093–1100, 2006.